An entire issue of the Journal of Law, Medicine, and Ethics is devoted to the notorious corruption of the pharmaceutical industry, and (of abiding interest to University Diaries) the way pharma-supported university research has corrupted universities.
The rise of pharmaceutical-firm-funded university research changes the social context of research, and along with it, the opportunities and constraints on researchers. [Garry C.] Gray uses a case study of a medical school professor’s first experience with pharmaceutical company-sponsored research in order to examine how funding arrangements can constrain research integrity. The case study reveals that there are conflicts between the norms of commercial firms and universities.